# An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

> **NCT07224373** · PHASE1 · RECRUITING · sponsor: **AstraZeneca** · enrollment: 24 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **BIOLOGICAL:** AZD0120 - Regimen 1
- **BIOLOGICAL:** AZD0120 - Regimen 2

## Key facts

- **NCT ID:** NCT07224373
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-09
- **Primary completion:** 2028-12-07
- **Final completion:** 2028-12-07
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07224373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07224373, "An Open-label Study of AZD0120 in Adults With Multiple Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07224373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*